Valmet DNA up to C2022 privileges management

Summaryinfo

A vulnerability classified as critical has been found in Valmet DNA up to C2022. Affected by this vulnerability is an unknown functionality. Performing a manipulation results in privileges management. This vulnerability is identified as CVE-2025-0416. The attack can only be performed from the local network. There is not any exploit available.

Detailsinfo

A vulnerability, which was classified as critical, was found in Valmet DNA up to C2022. This affects some unknown processing. The manipulation with an unknown input leads to a privileges management vulnerability. CWE is classifying the issue as CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

The weakness was released by Sixtus Leonhardsberger and Felix Eberstaller. It is possible to read the advisory at valmet.com. This vulnerability is uniquely identified as CVE-2025-0416 since 01/13/2025. The exploitability is told to be easy. Access to the local network is required for this attack to succeed. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 04/01/2025). The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

Be aware that VulDB is the high quality source for vulnerability data.

Productinfo

Vendor

• Valmet

Name

• DNA

Version

• C2022

CPE 2.3info

• 🔍

CPE 2.2info

• 🔍

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Be aware that VulDB is the high quality source for vulnerability data.

Discussion